Based on the BetterLife Pharma Inc stock forecast from 0 analysts, the average analyst target price for BetterLife Pharma Inc is not available over the next 12 months. BetterLife Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BetterLife Pharma Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, BetterLife Pharma Inc’s stock price was USD 0.08. BetterLife Pharma Inc’s stock price has changed by +5.56% over the past week, +12.59% over the past month and +76.74% over the last year.
No recent analyst target price found for BetterLife Pharma Inc
No recent average analyst rating found for BetterLife Pharma Inc
Company Overview BetterLife Pharma Inc
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for the treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream that has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Read Less
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the poten...Read More
Frequently Asked Questions About BetterLife Pharma Inc (BETRF) Stock
Stock Target Advisor's fundamental analysis for BetterLife Pharma Inc's stock is Bearish.
Unfortunately we do not have enough data on BETRF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BETRF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BETRF's stock to indicate if its overvalued.
The last closing price of BETRF's stock was USD 0.08.
The most recent market capitalization for BETRF is USD 9.48M.
Unfortunately we do not have enough analyst data on BETRF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BetterLife Pharma Inc's stock.
As per our most recent records BetterLife Pharma Inc has 0 Employees.
BetterLife Pharma Inc's registered address is 1275 West 6th Avenue, Vancouver, BC, Canada, V6H 1A6.
You can get more information about it from BetterLife Pharma Inc's website at https://www.abetterlifepharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About BetterLife Pharma Inc (BETRF) Stock
Stock Target Advisor's fundamental analysis for BetterLife Pharma Inc's stock is Bearish.
Unfortunately we do not have enough data on BETRF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BETRF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BETRF's stock to indicate if its overvalued.
The last closing price of BETRF's stock was USD 0.08.
The most recent market capitalization for BETRF is USD 9.48M.
Unfortunately we do not have enough analyst data on BETRF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BetterLife Pharma Inc's stock.
As per our most recent records BetterLife Pharma Inc has 0 Employees.
BetterLife Pharma Inc's registered address is 1275 West 6th Avenue, Vancouver, BC, Canada, V6H 1A6.
You can get more information about it from BetterLife Pharma Inc's website at https://www.abetterlifepharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BETRF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
